Prognostic factors after surgical resection of N1 non-small cell lung cancer

被引:17
|
作者
Mordant, P. [1 ]
Pricopi, C. [1 ]
Legras, A. [1 ]
Arame, A. [1 ]
Foucault, C. [1 ]
Dujon, A. [2 ]
Le Pimpec-Barthes, F. [1 ]
Riquet, M. [1 ]
机构
[1] Descartes Univ, Georges Pompidou European Hosp, Dept Gen Thorac Surg, Paris, France
[2] Cedar Surg Ctr, Bois Guillaume, France
来源
EJSO | 2015年 / 41卷 / 05期
关键词
Non-small cell lung cancer; N1; disease; Surgery; Survival; LYMPH-NODE INVOLVEMENT; STAGING PROJECT; CARCINOMA; SURVIVAL; CLASSIFICATION; DISEASE; PATTERN; SPREAD; NUMBER; IMPACT;
D O I
10.1016/j.ejso.2014.10.003
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objectives: Non-small cell lung carcinoma (NSCLC) with N1 involvement is associated with 5-year survival rates ranging from 7% to 55%. Numerous factors have been independently reported to explain this heterogeneous prognosis, but their relative weight on long-term survival is unknown. Methods: Patients who underwent surgical resection for NSCLC in two French centers from 1993 to 2010 were prospectively recorded and retrospectively reviewed. The overall survival (OS) of patients undergoing first-fine surgery for pN1 disease was analyzed according to the type of extension, number of metastatic LN, number and anatomic location of metastatic stations. Results: The study group included 450 patients (male 80.2%, mean age 63.3 +/- 9.9 years, 5-year overall survival 46%). The number of metastatic station was 1 in 340 (75.6%, single-station disease) and >= 2 in 110 patients (24.4%, multi-station disease). The number of metastatic stations was correlated with the number of metastatic LN (p < .001), and associated with adverse OS (p = .0014). The presence of intralobar metastatic LN (station 12-13-14) was associated with a mechanism of direct extension (p < .001), but did not impact OS (p = .71). The location of metastatic stations was of prognostic significance only in case of multi-station disease, with hilar (station 10) involvement being associated with adverse OS (p = .005). The 110 patients with multi-station pN1 disease and the 134 patients operated on for single-station pNON2 (skip-N2) disease during the study period yield comparable outcome (p = .52). Conclusions: In patients with resected pN1 NSCLC, the number of metastatic stations and their location in case of multi-station disease have a prognostic value. (C) 2014 Elsevier Ltd. All rights reserved.
引用
收藏
页码:696 / 701
页数:6
相关论文
共 50 条
  • [1] Prognostic Factors of Pathological N1 Non-small Cell Lung Cancer After Curative Resection Without Adjuvant Chemotherapy
    Moon, Youngkyu
    Sung, Sook Whan
    Park, Jae Kil
    Lee, Kyo Young
    Ahn, Seha
    [J]. WORLD JOURNAL OF SURGERY, 2019, 43 (04) : 1162 - 1172
  • [2] Prognostic Factors of Pathological N1 Non-small Cell Lung Cancer After Curative Resection Without Adjuvant Chemotherapy
    Youngkyu Moon
    Sook Whan Sung
    Jae Kil Park
    Kyo Young Lee
    Seha Ahn
    [J]. World Journal of Surgery, 2019, 43 : 1162 - 1172
  • [3] Factors predicting patterns of recurrence after resection of N1 non-small cell lung carcinoma
    Sawyer, TE
    Bonner, JA
    Gould, PM
    Foote, RL
    Deschamps, C
    Lange, CM
    Li, HZ
    [J]. ANNALS OF THORACIC SURGERY, 1999, 68 (04): : 1171 - 1176
  • [4] Outcome of Surgical Treatment for Clinical N1 Non-Small Cell Lung Cancer
    Nemoto, D.
    Ito, H.
    Tsuboi, T.
    Eriguchi, D.
    Samejima, J.
    Nagashima, T.
    Nakayama, H.
    Masuda, M.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S909 - S909
  • [5] Brain Metastases of Non-Small Cell Lung Cancer: Prognostic Factors in Patients with Surgical Resection
    Ramos Antuna, Aida
    Alvarez Vega, Marco
    Rodriguez Sanchez, Carmen
    Martin Fernandez, Vanesa
    [J]. JOURNAL OF NEUROLOGICAL SURGERY PART A-CENTRAL EUROPEAN NEUROSURGERY, 2018, 79 (02) : 101 - 107
  • [6] Chemotherapy and Surgical Resection for N1 Positive Non-small Cell Lung Cancer: Better Than Expected Outcomes
    White, Abby
    Kucukak, Suden
    Lee, Daniel N.
    Mazzola, Emanuele
    Dolan, Daniel
    Bueno, Raphael
    Jaklitsch, Michael T.
    Swanson, Scott J.
    [J]. SEMINARS IN THORACIC AND CARDIOVASCULAR SURGERY, 2021, 33 (04) : 1105 - 1111
  • [7] Prognostic Significance of Surgical-Pathologic N1 Lymph Node Involvement in Non-Small Cell Lung Cancer
    Demir, Adalet
    Turna, Akif
    Kocaturk, Celalettin
    Gunluoglu, Mehmet Zeki
    Aydogmus, Umit
    Urer, Nur
    Bedirhan, Mehmet Ali
    Gurses, Atilla
    Dincer, Seyit Ibrahim
    [J]. ANNALS OF THORACIC SURGERY, 2009, 87 (04): : 1014 - 1022
  • [8] Prognostic factor and treatment strategy for clinical N1 non-small cell lung cancer
    Masaya Tamura
    Isao Matsumoto
    Yusuke Tanaka
    Daisuke Saito
    Shuhei Yoshida
    Munehisa Takata
    Hirofumi Takemura
    [J]. General Thoracic and Cardiovascular Surgery, 2020, 68 : 261 - 265
  • [9] Prognostic biomarker study in pathologically staged N1 non-small cell lung cancer
    Komaki, R
    Milas, L
    Ro, JY
    Fujii, T
    Perkins, P
    Allen, P
    Sikes, CR
    Mountain, CF
    Ordonez, NG
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1998, 40 (04): : 787 - 796
  • [10] Prognostic factor and treatment strategy for clinical N1 non-small cell lung cancer
    Tamura, Masaya
    Matsumoto, Isao
    Tanaka, Yusuke
    Saito, Daisuke
    Yoshida, Shuhei
    Takata, Munehisa
    Takemura, Hirofumi
    [J]. GENERAL THORACIC AND CARDIOVASCULAR SURGERY, 2020, 68 (03) : 261 - 265